BioCentury
ARTICLE | Company News

Dermira, Maruho deal

September 26, 2016 7:00 AM UTC

Dermira granted Maruho exclusive, Japanese rights to develop and commercialize DRM04. Dermira will receive $25 million up front and is eligible for up to $70 million in regulatory and sales milestone...